Daewon Pharmaceutical Co., Ltd (003220) Revenue

― Followers

Daewon Pharmaceutical Co., Ltd Revenue

Daewon Pharmaceutical Co., Ltd had a revenue of 152.83B in the quarter ending Jun 30, 2026, with -3.31%. This bring the company's revenue in the last twelve months to 614.84B, Decreased 1.48%. In the fiscal year ending Dec 31, 2025, Daewon Pharmaceutical Co., Ltd had annual revenue of 605.64B with 1.25% growth.

Revenue (ttm)

614.84B

Revenue Growth

1.83%

P/S Ratio

0.28

Revenue/Employee

₩448,952,644

Employees

1,349

Market Cap

₩172.03B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	605.64B	7.47B	+1.25%
Dec 31, 2024	598.16B	71.21B	+13.51%
Dec 31, 2023	526.95B	48.07B	+10.04%
Dec 31, 2022	478.88B	124.71B	+35.21%
Dec 31, 2021	354.18B	45.68B	+14.81%
Dec 31, 2020	308.50B	-9.33B	-2.93%
Dec 31, 2019	317.83B	31.18B	+10.88%
Dec 31, 2018	286.65B	21.19B	+7.98%
Dec 31, 2017	265.46B	―	―